M. Vázquez-Carrera

Discipline

Géographie (1)

Type de document

Articles (9) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Animals (7) Mice (6) protéine (5) Treatment (5) Inflammation (5) Glucose (5) Transcription (4) Protein kinases (4) Insulin resistance (4) Growth (4) Expression (4) Transcription (4) Growth (4) stress (3) spectacle (3) gène (3) effet (3) Development (3) Control (3) Methods (3) Drama (3) Rats (3) Muscles (3) Lipids--Metabolism (3) Endoplasmic reticulum (3) Drama (3) Cells (3) Methods (3) recherche (2) association (2)

Documents écrit par M. Vázquez-Carrera (9) | parle de M. Vázquez-Carrera (0)

A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
D. Aguilar-Recarte et al.
Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations.
T. Espinosa-Jiménez et al. (11 juil. 2022)
PPARs as Key Mediators in the Regulation of Metabolism and Inflammation.
M. Vázquez-Carrera et al. (30 avr. 2022)
GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK.
D. Aguilar-Recarte et al. (10 août 2021)
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance.
D. Aguilar-Recarte et al. (9 août 2021)
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease.
M. Zarei et al.
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
L. Serrano-Marco et al. (2011)
Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
R. Rodríguez-Calvo et al. (2008)
Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
A. Planavila et al. (2005)